Producing heart cells from patients with inherited heart rhythm disorders from skin cells in order to develop new treatments

ISRCTN ISRCTN25297151
DOI https://doi.org/10.1186/ISRCTN25297151
Secondary identifying numbers V1; 09/02/2015
Submission date
04/02/2015
Registration date
13/02/2015
Last edited
03/08/2018
Recruitment status
Stopped
Overall study status
Stopped
Condition category
Circulatory System
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Background and study aims
Inherited Arrhythmia Syndromes (IAS) are caused by changes (mutations) in the genetic make-up of the heart (genes form the pattern of molecules within cells that are inherited from our parents). Heart cells are electrically charged, like a battery so any changes in the make-up of the cell (gene mutations) can cause disruptions to the rhythm of the heart. The heart beat can become irregular (arrhythmia) and sometimes it can stop completely, leading to death. Studying living heart cells is very difficult but this study hopes to take advantage of a new technique that allows scientists to obtain heart cells from samples of skin taken from patients with IAS. The cells obtained from such samples are similar enough to the cells of the heart muscle it is possible to study to effect of the mutations on the electrical properties of the heart. We can determine the cause of arrhythmias and sudden death and then test new therapies within a laboratory. Ultimately this will increase our understanding of IAS and lead to targeted treatments.

Who can participate?
Adult patient with confirmed diagnosis of inherited condition OR family member of patient with inherited condition

What does the study involve?
Collection of sample tissues.

What are the possible benefits and risks of participating?
The benefit is increased understanding of IAS leading to the development of new treatments. There are no risks, other than slight discomfort associated with obtaining a skin biopsy.

Where is the study run from?
Central Manchester NHS Foundation Trust (UK)

When is the study starting and how long is it expected to run for?
From April 2015 to March 2017

Who is funding the study?
University of Manchester

Who is the main contact?
Dr Luigi Venetucci
luigi.venetucci@manchester.ac.uk

Contact information

Dr Luigi Venetucci
Scientific

Institute of Cardiovascular Sciences
University of Manchester
Core Technology Facility
Grafton Street
Manchester
M13 9NT
United Kingdom

Phone +44 (0)161 275 1202
Email luigi.venetucci@manchester.ac.uk

Study information

Study designProspective tissue sample and data collection
Primary study designInterventional
Secondary study designTissue sample
Study setting(s)Hospital
Study typeScreening
Scientific titleUse of cardiac myocytes derived from skin fibroblasts to study patients with Inherited Arrhythmia Syndromes (IAS)
Study objectivesDiscovery science - no hypothesis
Ethics approval(s)RES Committee North West - Greater Manchester Central, 29/04/2015, ref: 15/NW/0301
Health condition(s) or problem(s) studiedInherited Arrhthymia Syndromes
InterventionSkin biopsy in order to derive cardiac cells
Intervention typeProcedure/Surgery
Primary outcome measureDerivation of cardiac myocytes from skin fibroblasts obtained from patients affected by inherited arrhythmia syndromes and their family members.
Secondary outcome measures1. Identification of new genes in patients with inherited arrhythmia syndromes
2. Testing of new treatment strategies for inherited cardiac conditions
Overall study start date01/04/2015
Completion date30/03/2017
Reason abandoned (if study stopped)Lack of staff/facilities/resources

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
SexBoth
Target number of participants50
Key inclusion criteria1. Confirmed diagnosis of inherited condition OR family member of patient with inherited condition
2. Aged > 18
3. Informed consent available
Key exclusion criteria1. Unwilling or unable to give informed consent
2. Age <18
Date of first enrolment01/04/2015
Date of final enrolment30/03/2017

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

Central Manchester NHS Foundation Trust
Manchester Royal infirmary
Grafton Street
Manchester
M13 9WL
United Kingdom

Sponsor information

University of Manchester
University/education

3.53 Simon Building
Oxford Road
Manchester
M13 9PL
England
United Kingdom

Phone +44 (0)161 275 8795
Email fmhsethics@manchester.ac.uk
ROR logo "ROR" https://ror.org/027m9bs27

Funders

Funder type

University/education

University of Manchester
Government organisation / Universities (academic only)
Alternative name(s)
The University of Manchester, University of Manchester UK, University of Manchester in United Kingdom, UoM
Location
United Kingdom

Results and Publications

Intention to publish date31/12/2017
Individual participant data (IPD) Intention to shareYes
IPD sharing plan summaryAvailable on request
Publication and dissemination planPlan to publish in high impact peer-reviewed journals of Cardiology but this is unlikely to be before 2017.
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
HRA research summary 28/06/2023 No No

Editorial Notes

03/08/2018: This trial did not commence due to a change in study personnel making it impossible to conduct this trial.
24/03/2016: Ethics approval information added.